SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001753926-24-001824
Filing Date
2024-11-07
Accepted
2024-11-07 17:01:47
Documents
17
Period of Report
2024-11-07
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K g084539_8k.htm   iXBRL 8-K 38982
2 EXHIBIT 3.1I g084539_ex3-1.htm EX-3.1I 3769
3 GRAPHIC g084539_ex3jpg1.jpg GRAPHIC 96342
4 GRAPHIC g084539_ex3jpg2.jpg GRAPHIC 283955
5 GRAPHIC g084539_ex3jpg3.jpg GRAPHIC 35983
  Complete submission text file 0001753926-24-001824.txt   794766

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE lipo-20241107.xsd EX-101.SCH 3012
7 XBRL LABEL FILE lipo-20241107_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE lipo-20241107_pre.xml EX-101.PRE 22357
19 EXTRACTED XBRL INSTANCE DOCUMENT g084539_8k_htm.xml XML 3974
Mailing Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208
Business Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208 412-901-0315
LIPELLA PHARMACEUTICALS INC. (Filer) CIK: 0001347242 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41575 | Film No.: 241436901
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)